BlackRock’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-235,879
| Closed | -$245K | – | 5127 |
|
|
2019
Q1 | $245K | Buy |
235,879
+8,242
| +4% | +$8.56K | ﹤0.01% | 4164 |
|
|
2018
Q4 | $169K | Sell |
227,637
-13,566
| -6% | -$10.1K | ﹤0.01% | 4222 |
|
|
2018
Q3 | $510K | Buy |
241,203
+3,064
| +1% | +$6.48K | ﹤0.01% | 4071 |
|
|
2018
Q2 | $550K | Buy |
238,139
+17,133
| +8% | +$39.6K | ﹤0.01% | 4018 |
|
|
2018
Q1 | $702K | Sell |
221,006
-3,151
| -1% | -$10K | ﹤0.01% | 3920 |
|
|
2017
Q4 | $919K | Sell |
224,157
-568,181
| -72% | -$2.33M | ﹤0.01% | 3866 |
|
|
2017
Q3 | $3.58M | Buy |
792,338
+10,565
| +1% | +$47.7K | ﹤0.01% | 3503 |
|
|
2017
Q2 | $2.6M | Sell |
781,773
-912,592
| -54% | -$3.04M | ﹤0.01% | 3575 |
|
|
2017
Q1 | $15.6M | Buy |
1,694,365
+1,692,635
| +97,840% | +$15.6M | ﹤0.01% | 2881 |
|
|
2016
Q4 | $13K | Sell |
1,730
-165
| -9% | -$1.24K | ﹤0.01% | 3293 |
|
|
2016
Q3 | $21K | Buy |
1,895
+419
| +28% | +$4.64K | ﹤0.01% | 3220 |
|
|
2016
Q2 | $18K | Buy |
1,476
+245
| +20% | +$2.99K | ﹤0.01% | 3265 |
|
|
2016
Q1 | $12K | Buy |
1,231
+656
| +114% | +$6.4K | ﹤0.01% | 3046 |
|
|
2015
Q4 | $13K | Buy |
575
+280
| +95% | +$6.33K | ﹤0.01% | 2764 |
|
|
2015
Q3 | $5K | Hold |
295
| – | – | ﹤0.01% | 3040 |
|
|
2015
Q2 | $7K | Hold |
295
| – | – | ﹤0.01% | 3002 |
|
|
2015
Q1 | $8K | Hold |
295
| – | – | ﹤0.01% | 2858 |
|
|
2014
Q4 | $6K | Hold |
295
| – | – | ﹤0.01% | 3014 |
|
|
2014
Q3 | $6K | Hold |
295
| – | – | ﹤0.01% | 3014 |
|
|
2014
Q2 | $7K | Buy |
+295
| New | +$7K | ﹤0.01% | 3007 |
|